College of Physicians and Surgeons at Columbia University. Prior to beginning her fellowship, Dr. Chang completed residency training in primary care general internal medicine at UCSF. She has completed an M.P.H. degree at UCB.

SUSAN BARTLETT FOOTE is an associate professor of business and public policy at the Walter A. Haas School of Business, University of California, Berkeley and a member of the faculty at the School of Public Health at Berkeley. Professor Foote has written widely in the field of safety regulation and business-government relations, with a special emphasis on medical devices. Her work has appeared in the Journal of Health Policy, Politics and Law, Milbank Quarterly, and numerous law and business journals. Her book on the influence of public policy on medical device innovation is forthcoming from California University Press. Professor Foote is a member of the Institute of Medicine (IOM) Committee on Technological Innovation in Medicine and the Forum on Drug Development. She served as a consumer representative for the Office of Device Evaluation at the Food and Drug Administration and contributed to reports of the Office of Technology Assessment of the U.S. Congress. She holds a J.D. degree from Boalt Hall, UCB. In 1990-1991, she is a Robert Wood Johnson Health Policy Fellow working on issues of medical technology in the U.S. Senate.

ANNETINE C. GELIJNS joined the Institute of Medicine (IOM) as an international fellow, and now is the study director for the IOM Committee on Technological Innovation in Medicine. Before joining the IOM, she was senior researcher for the Project on Future Health Care Technology, cosponsored by the European office of the World Health Organization (WHO) and the Dutch Government. From 1983 to 1985 Ms. Gelijns worked for the Steering Committee on Future Health Scenarios, where she helped develop models for long-term health planning in the areas of cancer, cardiovascular disease, and aging. At the time, she had a joint appointment with the Staff Bureau for Health Policy Development, the Department of Health, the Netherlands. Ms. Gelijns has been a consultant to various national and international organizations, including the WHO and the Organization for Economic Cooperation and Development. Her research interests are in the dynamics of the development process of drugs, devices and clinical procedures. In 1983 she received her LL.M. degree from the University of Leyden, and she will receive her Ph.D. degree from the medical faculty, the University of Amsterdam in August 1991. She is a member of the board of the International Society on Technology Assessment in Health Care.

HENRY GRABOWSKI has been at Duke University since 1972, where he is currently professor of economics. He is also director of the Program in Pharmaceuticals and Health Economics, which is part of the Center for

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement